ROSEMARY MAZANET - 28 Jun 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
ONCT
Transactions as of
28 Jun 2023
Transactions value $
$0
Form type
4
Filing time
30 Jun 2023, 16:00:16 UTC
Previous filing
05 May 2023
Next filing
07 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCT Stock Options Award $0 +25K $0.00 25K 28 Jun 2023 Common Stock 25K $0.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.